TSE:BLU BELLUS Health (BLU) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About BELLUS Health Stock (TSE:BLU) 30 days 90 days 365 days Advanced Chart Get BELLUS Health alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume28,666 shsAverage Volume59,471 shsMarket CapitalizationC$2.47 billionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BELLUS Health Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. BELLUS Health Inc. was incorporated in 1993 and is based in Laval, Canada. As of June 28, 2023, BELLUS Health Inc. operates as a subsidiary of GSK plc. Read More Receive BLU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BELLUS Health and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLU Stock News HeadlinesBlue Cross of Minnesota agrees to legal settlement for better mental health coverageNovember 1, 2024 | startribune.comSBirmingham lawyers help secure $2.8 billion Blue Cross settlement; largest for health care antitrust caseOctober 15, 2024 | msn.comWashington prepares for warWhile the headlines obsess over overseas conflicts, Washington has been quietly preparing for something much bigger here at home. Emergency powers are being invoked, trillions are being mobilized, and the scale rivals anything we’ve seen since WWII. According to Porter Stansberry and Jeff Brown, a new economic arms race is already underway — one that could reshape markets, redirect capital, and impact billions of lives. They’ve just released an urgent briefing that explains what’s really happening behind the scenes, and which companies are positioned to benefit most.September 5 at 2:00 AM | Porter & Company (Ad)We Tested (and Rated!) All the Desks and Sideboards at Blu Dot — Here Are the Best to Suit Your Style and SpaceOctober 4, 2024 | yahoo.comBaptist Health, Florida Blue deal comes as relief to local first respondersOctober 1, 2024 | msn.com‘Come to an agreement:’ Jacksonville first responders stuck in between Florida Blue, Baptist HealthSeptember 30, 2024 | yahoo.comBaptist Health, Florida Blue reach agreement after months-long negotiationsSeptember 30, 2024 | msn.comFlorida Blue and Baptist Health say talks will continue even if they don't meet deadlineSeptember 30, 2024 | msn.comSee More Headlines BLU Stock Analysis - Frequently Asked Questions How do I buy shares of BELLUS Health? Shares of BLU stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers. What other stocks do shareholders of BELLUS Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that BELLUS Health investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Advanced Micro Devices (AMD), Algonquin Power & Utilities (AQN), BCE (BCE), Canadian Natural Resources (CNQ) and Nutrien (NTR). Industry, Sector and Symbol Stock ExchangeTSE SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolTSE:BLU CIKN/A Webwww.bellushealth.com Phone+1-450-6804500FaxN/AEmployees74Year FoundedN/AProfitability EPS (Trailing Twelve Months)C($0.96) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-C$86.79 million Net MarginsN/A Pretax MarginN/A Return on Equity-26.76% Return on Assets-16.70% Debt Debt-to-Equity Ratio0.32 Current Ratio33.42 Quick Ratio16.40 Sales & Book Value Annual SalesC$16 thousand Price / Sales0.00 Cash FlowN/A Price / Cash Flow4.67 Book ValueC$2.91 per share Price / BookN/AMiscellaneous Outstanding Shares126,810,000Free FloatN/AMarket CapC$2.47 billion OptionableNot Optionable Beta-0.28 The 10 Best AI Stocks to Own in 2025Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free Report This page (TSE:BLU) was last updated on 9/5/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredHow “Trump’s New Dollar” Could Impact Your WealthPresident Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...Brownstone Research | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredWarren Buffett Issues Cryptic Warning on U.S. DollarImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | SponsoredOne tiny company just cracked Google’s $19B problemFor decades, this “AI metal” was trapped in labs, too slow and expensive to ever reach mass production. The...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BELLUS Health Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BELLUS Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
